Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Newborn Screening Market, by Product Type
1.4.2 North America Newborn Screening Market, by Test Type
1.4.3 North America Newborn Screening Market, by End User
1.4.4 North America Newborn Screening Market, by Technology
1.4.5 North America Newborn Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Newborn Screening Market
Chapter 4. North America Newborn Screening Market by Product Type
4.1 North America Consumables Market by Country
4.2 North America Instrument Market by Country
Chapter 5. North America Newborn Screening Market by Test Type
5.1 North America Blood Test Market by Country
5.2 North America Hearing Screening Test Market by Country
5.3 North America Heart screening Market by Country
Chapter 6. North America Newborn Screening Market by End User
6.1 North America Hospitals Market by Country
6.2 North America Clinical Laboratories Market by Country
Chapter 7. North America Newborn Screening Market by Technology
7.1 North America Tandem Mass Spectrometry (TMS) Market by Country
7.2 North America Molecular Assays Market by Country
7.3 North America Immunoassays & Enzymatic Assays Market by Country
7.4 North America Hearing Screen Technology Market by Country
7.5 North America Pulse Oximetry Screening Technology Market by Country
7.6 North America Others Market by Country
Chapter 8. North America Newborn Screening Market by Country
8.1 US Newborn Screening Market
8.1.1 US Newborn Screening Market by Product Type
8.1.2 US Newborn Screening Market by Test Type
8.1.3 US Newborn Screening Market by End User
8.1.4 US Newborn Screening Market by Technology
8.2 Canada Newborn Screening Market
8.2.1 Canada Newborn Screening Market by Product Type
8.2.2 Canada Newborn Screening Market by Test Type
8.2.3 Canada Newborn Screening Market by End User
8.2.4 Canada Newborn Screening Market by Technology
8.3 Mexico Newborn Screening Market
8.3.1 Mexico Newborn Screening Market by Product Type
8.3.2 Mexico Newborn Screening Market by Test Type
8.3.3 Mexico Newborn Screening Market by End User
8.3.4 Mexico Newborn Screening Market by Technology
8.4 Rest of North America Newborn Screening Market
8.4.1 Rest of North America Newborn Screening Market by Product Type
8.4.2 Rest of North America Newborn Screening Market by Test Type
8.4.3 Rest of North America Newborn Screening Market by End User
8.4.4 Rest of North America Newborn Screening Market by Technology
Chapter 9. Company Profiles
9.1 General Electric (GE) Co. (GE Healthcare)
9.1.1 Company Overview
9.1.1 Financial Analysis
9.1.2 Segmental and Regional Analysis
9.1.3 Research & Development Expense
9.1.4 Recent strategies and developments:
9.1.4.1 Acquisition and Mergers:
9.1.5 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Bio-Rad laboratories, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.4 Natus Medical Incorporated
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Acquisition and Mergers:
9.5 Masimo Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Product Launches and Product Expansions:
9.5.5.2 Approvals and Trials:
9.6 Waters Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 PerkinElmer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Approvals and Trials:
9.8 AB Sciex LLC (Danaher Corporation)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.9 Medtronic PLC (Covidien plc)
9.9.1 Company overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 SWOT Analysis
9.10. Trivitron Healthcare Pvt. Ltd.
9.10.1 Company Overview
Unique Offerings 